International Health Regulations Amendments

Ashley Dalton Excerpts

Monday 14th July 2025 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

I would like to update the House that the UK Government have accepted the amendments to the International Health Regulations 2005, which were agreed by countries at the World Health Assembly on 1 June 2024.

The IHRs are an important, legally binding technical framework that helps to prevent and protect against the international spread of disease. The existing IHRs, agreed to in 2005, have helped the UK to prevent, detect and respond to global health emergencies such as Ebola and avian influenza by giving the UK timely access to verified information not in the public domain, helping us to mount a rapid and appropriate public health response.

The amendments to the IHRs, agreed at the WHA on 1 June 2024, aim to reflect lessons learned from recent global health emergencies, such as the covid-19 pandemic, including by improving information sharing and collaboration for public health emergency response. On 19 September 2024, the World Health Organisation’s director general formally notified all states parties of the official amendments adopted by the WHA. From that date of notification, the UK had 10 months in which to complete the domestic review of IHR amendments and then notify the WHO director general on whether the UK wished to reject or reserve on any or all of the amendments by 19 July 2025. The amendments, all of which are adopted, will come into force for the UK in September 2025.

Department of Health and Social Care officials led work across Government to confirm the implications of the amendments for the UK. Officials also worked with their counterparts in the devolved Administrations and in our overseas territories and Crown dependencies to ensure that all relevant territories are considered. This analysis concluded that the amendments are in the national interest of the UK and informed the decision to accept all of the amendments. Acceptance of, and compliance with, the amendments does not impact the UK’s right to make domestic decisions on national measures concerning public health. The analysis found that where the amendments placed new obligations on the UK and other member states, the UK is already compliant with all but three areas. To be compliant with these amendments, the UK will:

Designate the UK Health Security Agency as the national IHR authority to oversee overall implementation of the IHR and ensure co-ordination within the UK;

Factor the new tier of alert “pandemic emergency” into domestic pandemic preparedness planning across Government, the devolved Governments, the Crown dependencies and the UK overseas territories; and

Provide representation for the UK on the WHO member state-led IHR implementation committee and provide representation, as required, on the technical sub-committee of the implementation committee.

Please be assured that respect for member state sovereignty is an underlying principle of the IHR, and at no point during negotiations about the amendments were there proposals that would give the WHO powers to impose domestic decisions on the UK, such as those regarding lockdowns, mandatory vaccinations, mask wearing or border restrictions. While the WHO director general may make recommendations on international responses following the declaration of a public health emergency of international concern or a pandemic emergency, these recommendations are non-binding and it is for member states to determine their domestic response.

[HCWS818]

Children’s Health

Ashley Dalton Excerpts

Thursday 10th July 2025 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

I congratulate my hon. Friend the Member for Stroud (Dr Opher) on securing this debate. He is a tireless advocate for children across the country. I also pay tribute to his campaigning on social prescribing before he came to this place, because it is now a key part of our 10-year plan for health.

This issue is dear to my heart. One of the reasons I stood for Parliament is that nearly a quarter of the kids in Skelmersdale, the biggest town in my constituency, live in poverty. As many colleagues have pointed out, the state of children’s health is a national scandal. As my hon. Friend the Member for Stroud said, and as was referred to by the shadow Minister, this is a complex issue that straddles a variety of areas. It is about active travel—and I am delighted that the Minister responsible for active travel, my hon. Friend the Member for Wakefield and Rothwell (Simon Lightwood), is on the Front Bench with me today—as well as air pollution and access to green spaces.

My hon. Friend the Member for Warrington South (Sarah Hall) highlighted links between children’s health, education and poverty. The hon. Member for Mid Dunbartonshire (Susan Murray) made a contribution, and her expertise in diet and nutrition was really insightful. My hon. Friend the Member for Mitcham and Morden (Dame Siobhain McDonagh) spoke about children with life-limiting illnesses and end-of-life care and palliative care for children.

My hon. Friend the Member for Lowestoft (Jess Asato) talked about junk food advertising and dentistry. My hon. Friend the Member for Bournemouth East (Tom Hayes) talked about family hubs and Best Start, which we have launched this week, children’s health and social care infrastructure and the third sector. I was really pleased that my hon. Friend the Member for Ilford South (Jas Athwal) raised the issue of fast food outlets and junk food advertising, which I will cover in my response.

My hon. Friend the Member for Mansfield (Steve Yemm) talked about children, young people and cancer, and mentioned the Teenage Cancer Trust, which I met recently along with my hon. Friend, and I was delighted to do so. My hon. Friend the Member for Stafford (Leigh Ingham) spoke about how important play and sport are. We are working across Departments in our mission-led Government to deliver the healthiest generation ever. I can confirm that the NHS works with the Starlight charity to support the provision of play facilities within hospitals.

Over 2 million children are not active, and we need to change that. The Department of Health and Social Care, the Department for Education and the Department for Culture, Media and Sport are committed to investing in school sport and have confirmed funding for next year’s primary PE and sport premium. We are working across Government to develop new school sports partnerships, and a national network model was announced by the Prime Minister in June.

Lord Darzi’s review set out in black and white how badly the previous Government let our children down. Tooth decay is the most common reason why children aged five to nine are admitted to hospital. Referrals for mental health services for children and young people have tripled since 2016, and waiting lists for health services have grown faster for children than for adults. That must change, and it will change.

This Government are committed to raising the healthiest generation of children ever, and work to deliver this ambition has already begun. One of the biggest things we can do to improve a child’s life chances is safeguard their mental health. That is why by the end of this Parliament we will put a mental health support team in every school in England to break the vicious cycle of poor mental health, low attendance and bad behaviour.

My right hon. Friend the Education Secretary is rolling out free breakfast clubs so that kids start school with hungry minds not hungry bellies. To combat tooth decay, we have invested £11 million in supervised tooth brushing for three to five-year-olds in our most deprived communities. We are going further than ever before to tackle long waiting times for children through our elective reform plan. We have already delivered more than 4 million appointments, which is double what we promised in our manifesto.

On children’s social care and neglect, which the shadow Minister talked about, we are committed to rebalancing the system towards earlier intervention. That is why the spending review committed to reforming children’s social care, including through a new £555 million transformation fund.

I thank my hon. Friend the Member for Mitcham and Morden for raising the important matter of funding for children’s hospices, and I agree with her about their crucial role. As she said, we have committed £26 million for children’s hospices this year, alongside £100 million of capital funding. Future funding will be announced in due course.

My hon. Friend the Member for Stroud mentioned that it is crucial to involve young people in our conversations and policy development. I spoke recently at a Children’s Hospital Alliance event and a Children’s Commissioner roundtable, where I listened directly to the views and voices of children and young people to make sure that they fed into the 10-year health plan. Our neighbourhood health offer builds on that feedback, and we have re-established the children and young people’s cancer taskforce and insisted that children and young people are around that table.

Last week we published our 10-year plan for health, which sets out how we will fix our broken NHS and make it fit for today’s children and for future generations. We on the Government Benches will not rest until every working person receives the same kind of healthcare that the wealthy expect.

The three shifts that underpin our plan are the building blocks to ensure that children get the best start in life. The first is from treatment to prevention. We know that a baby’s first 1,001 days, from conception to the age of two, set the foundations for later years, so we are establishing Best Start family hubs, building on the legacy of Sure Start, which was a lifeline for working families under the last Labour Government. Earlier this week we published the “Giving every child the best start in life” strategy, and we will provide funding to every local authority in England for Best Start family hubs, because no parent should have to face the challenges of parenthood alone.

We are also taking firm action on obesity, which many Members raised today, and which affects nearly one in five children leaving primary school. Our action includes restricting junk food advertising, banning the sale of high-caffeine energy drinks, updating school food standards, strengthening the soft drinks industry levy, introducing healthy food sales reporting and, ultimately, using that reporting to set new sales targets.

The Government have regulations in place to set nutritional, compositional and labelling standards for commercial baby food, and we continue to challenge the industry to take further action, providing advice and guidance for parents. Enforcement of nutrition legislation is the responsibility of local authorities. Good nutrition in the early years is vital. We recognise that there are opportunities to support parents and make the healthier choice easier by encouraging businesses to improve baby foods. I will set out our plans on that soon.

We are also determined to fix the special educational needs and disability system and restore the trust of parents by ensuring that schools have the tools to better identify and support children before issues escalate to crisis point. This autumn, the Government will bring forward a schools White Paper, which will detail our approach to SEND reform, ensuring joined-up support for children and young people.

On the shift from analogue to digital, going beyond the paper red book, the “My Children” function on the NHS app will become the digital companion for parents to access their child’s health information throughout their childhood. Over time, parents will be able to record their children’s habits and developmental milestones, and use artificial intelligence to access help and advice when needed.

On the third shift, from hospital to community, we will roll out neighbourhood health centres in every community, building care closer to where children live, learn and play. That includes multidisciplinary teams made up of GPs, nurses, health visitors, paediatricians, mental health, social workers and the third sector, providing joined-up preventive care and supporting children with complex and chronic needs.

Before I wrap up, I want to say a few words on inequalities. Building a fair Britain is central to our 10-year plan. As the Secretary of State for Health and Social Care said in Blackpool last month, we will review how health need is reflected in funding for general practice, with a sharp focus on money following need. Child poverty is a stain on our country. We are determined to fix this, which is why we are rolling out free school meals to all children in households on universal credit. From April 2026, we will be increasing the value of Healthy Start payments by 10%. I am also a member of the child poverty taskforce, and the strategy on this will be published later this year.

I again thank my hon. Friend the Member for Stroud for raising this vital topic and all other colleagues for speaking today. When he launched our manifesto, my right hon. Friend the Prime Minister promised to restore

“The bond that reaches through the generations and says—this country will be better for your children.”

That is what we are doing with our 10-year plan. I look forward to working with my hon. Friend and all other colleagues to get this done.

Clinical Indemnities Reform

Ashley Dalton Excerpts

Tuesday 8th July 2025 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

My noble friend the Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health (Baroness Merron) has made the following written statement:

I am pleased to report that through the National Institute for Health and Care Research, my Department has commissioned an independent evaluation of the sector-led voluntary code of practice launched by medical defence organisations on 6 January this year.

The intention to develop a sector-led code to address concerns highlighted by the Paterson inquiry report was previously announced in March 2024. The code has now been launched as planned by the Medical Defence Union, Medical Protection Society and Medical and Dental Defence Union of Scotland.

Clinical negligence cover is the system that enables patients to receive compensation if they are harmed during treatment through the cover held by regulated healthcare professionals such as doctors, nurses and dentists. The code aims to improve the transparency and clarity of MDOs’ operations and the discretionary indemnity they provide healthcare professionals whose activities (e.g. private practice) are not covered by state schemes. With these improvements and healthcare professionals’ better understanding of the appropriate cover required for their scope of practice, there will be greater protection for patients’ access to compensation if harmed during treatment.

The full code, which can be accessed on the MDOs’ websites, sets out seven core principles described under the following headings:

Corporate governance

Fair member treatment

Scope of benefit available to members

Decision making

Independent complaints review service

Financial attestation

Statement of adherence

This short-term evaluation focuses on the implementation of the code. We will be exploring a further commission to assess impact and whether further interventions are required.

We continue to consider further policy options to reform the clinical negligence cover system such as addressing cover for criminal acts to improve patients’ access to compensation, and I will provide an update in due course.

[HCWS791]

Alcohol and Cancer

Ashley Dalton Excerpts

Tuesday 8th July 2025 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

It is an honour to serve under your chairship, Mr Stuart, as ever. I thank my hon. Friend the Member for Lancaster and Wyre (Cat Smith) for securing this important debate during Alcohol Awareness Week. The Government recognise that for too long there has been an unwillingness to lead on issues such as alcohol harm. It is unacceptable that alcohol-specific deaths are at the highest rates on record, having increased dramatically during the pandemic.

As my hon. Friend stated, alcohol is a type 1 carcinogen, meaning there is strong evidence that drinking alcohol can cause several types of cancer, as well as contributing to more than 200 other health conditions, including liver disease, high blood pressure, stroke and heart disease. That places an incredible and preventable pressure on our NHS: in England alone, of more than 1 million hospital admissions last year, 103,000 were due to alcohol-related cancers.

Today, we have heard from many colleagues about the variety of issues that alcohol can cause. The hon. Member for East Londonderry (Mr Campbell) talked about the cost to Government and to society, which I will address later; the hon. Member for Strangford (Jim Shannon) discussed information and the importance of education; my hon. Friend the Member for Easington (Grahame Morris) mentioned the real impacts on communities and families in the north-east; my hon. Friend the Member for Coatbridge and Bellshill (Frank McNally) talked about how important early intervention is; and my hon. Friend the Member for Blackpool North and Fleetwood (Lorraine Beavers) raised the links to poverty and under-investment.

As for the impacts, alcohol kills. Last year, in England, more than 22,600 deaths were alcohol related, with more than 8,000 entirely due to alcohol—an all-time high, with rates still increasing by 4% each year. The rate of alcohol-related deaths is 1.7 times higher in the most deprived local authorities, meaning that alcohol is a major contributor to the levels of health inequality in this country. Alcohol also kills young—in 2015, in England, an estimated 167,000 years of working life were lost due to alcohol-related deaths. That amounts to about 16% of all working years lost.

The hon. Member for East Londonderry asked about the cost to Government and society. Alcohol harms us massively. The estimated annual cost of alcohol-related harms in England is £27 billion, driven by the impact of alcohol-related illnesses and injuries on NHS services and alcohol’s high contribution to levels of economic inactivity, crime and disorder. Each year, £13 billion is raised in tax revenue from alcohol.

The guideline on alcohol consumption produced by the four nations’ chief medical officers advises that drinking any level of alcohol increases the risk of a range of cancers, including mouth, bowel, stomach, liver and breast cancers, and that the risk of harm increases with the frequency and quantity of alcohol consumed. In 2020, alcohol was estimated to have caused about 17,000 new cases of cancer in the UK. One study estimated that between 2015 and 2035 there would be 135,000 cancer deaths due to alcohol in England. In terms of cancer risk, drinking a bottle of wine is the equivalent of smoking five cigarettes for a man, and 10 cigarettes for a woman.

We also cannot overlook the impact that being exposed to multiple risk factors has in increasing the risk of developing certain conditions. For instance, the risk of developing head and neck cancer is 3.8 times higher among those who drink and smoke than those who partake in only one of those behaviours. That is why a holistic approach is needed to our health, with people supported to address all risk factors for poor health together.

We are continuing to invest in local alcohol treatment services to make sure that people have access to the treatment they need. While those services are primarily focused on supporting people to become free from alcohol dependence, they are also an important setting for providing health information for people with alcohol dependence, identifying alcohol-related health conditions and ensuring that people can access specialist assessment and care.

In the 12 months to February 2025, nearly 140,000 people were treated for their alcohol needs—9,000 more than in the previous year. In the coming months, the Department of Health and Social Care will publish the first ever UK guidelines on alcohol treatment. The guidelines will include recommendations on healthcare assessments for alcohol-related conditions and will strengthen pathways between specialist alcohol and drug treatment services and the wider healthcare system.

The incidence of liver cancer has increased by 50% over the past decade and is expected to rise further. A large percentage of liver cancer is caused by alcohol-related liver disease, which in its early stages has no outward symptoms. If we can find liver disease by screening at-risk populations, there is an opportunity to halt its progress and monitor for the development of cancer. To identify people at high risk of liver cancer due to liver cirrhosis or advanced fibrosis, the NHS in England has been piloting community liver health checks in 20 areas, and liver primary care case-finding pilots across 12 primary care networks. Those pilot sites have screened nearly 125,000 people, and over 9,000 of them have been enrolled in liver cancer surveillance.

As the Secretary of State has made clear since we came into power, one of the three big shifts that we want to see in the NHS is a shift from treatment to prevention. The complex challenge of cancer prevention will not be solved by a single solution.

[Grahame Morris]

I am listening intently, but I may have missed an important point, so I wonder whether it would bear repeating. The Minister indicated that a treatment framework will be published very shortly. Will that be informed by an alcohol strategy that the Government will also produce? We have not had one since 2012.

[Ashley Dalton]

A number of hon. Members have asked about a national alcohol strategy. We are continuing to work across Government to understand what other measures might be needed to reduce the negative impact of excessive alcohol consumption. I meet regularly with Ministers from across Government to discuss how we take that forward.

The drug and alcohol area of work is led by the Home Office. There are no plans to introduce such a strategy at this stage, but I expect further information on how we will deal with alcohol prevention and cancer in the national cancer plan, which, as I was just about to state, the Government will publish later this year. This plan will build on the progress of the 10-year health plan, which was published last week, and will continue the work to shift from treatment to prevention, including for alcohol-related cancer risks.

We are taking steps now. The 10-year health plan for England includes an important commitment to ensure that health warnings and nutritional information are legally required on alcohol labels. That is a crucial step in supporting people to make healthier choices when it comes to alcohol. There is international support for that approach. The World Health Organisation’s “Global alcohol action plan 2022-2030” recommends that countries should implement labelling requirements to display relevant information to support health protection.

Despite the fact that alcohol is a group 1 carcinogen, alcohol labels are currently required to display far less information than those for food, soft drinks, alcohol-free products or tobacco. We know that voluntary regulation does not lead to consistently good practice in alcohol labelling, so we need to ensure that there is a legal requirement to display certain information on alcohol products. We also know that consumers want more information on alcohol labels: a 2021 survey showed that 75% wanted unit information, 61% wanted calorie information, and 53% wanted sugar content to be displayed. Those results are supported by those of the 2023 alcohol toolkit study, which found that public support for health warning labels was 61.5%, and that 78% supported nutritional information labelling.

There is widespread awareness among people in the UK that smoking causes cancer. That information is important to supporting behavioural change. But public awareness that alcohol is carcinogenic is far too low. In a 2016 study of 2,100 adults, only 13% named cancer as a health risk from hazardous drinking. Another recent international study found that only 15% were aware that alcohol can cause breast cancer.

We will soon share details of our consultation to determine the best ways to get the necessary information to consumers. We welcome the support and input of parliamentarians in taking that important piece of work forward, but let me be absolutely clear: we will consult on how we will implement mandatory labelling, not whether we will do so. This Government are determined to introduce mandatory labelling for alcohol.

We have also discussed various other options available for controlling alcohol consumption. My hon. Friends the Members for Paisley and Renfrewshire North (Alison Taylor), for Easington and for Lancaster and Wyre talked about minimum unit pricing. The Government are acutely aware of the cost of living pressures being felt by families and individuals, and the difficult economic conditions facing the country. Although interventions that affect the price of alcohol have been shown to be effective at directly reducing alcohol harms, the Government have chosen not to pursue policies that could exacerbate economic issues at this time, although we will continue to keep those options under consideration.

The Department for Culture, Media and Sport is the branch of Government responsible for advertising and marketing. The Advertising Standards Authority is responsible for regulating advertising through codes set by the Committee of Advertising Practice and the Broadcast Committee of Advertising Practice. Those codes are enforced by the ASA, include specific rules about how alcohol can be advertised, and recognise the social imperative of ensuring that alcohol advertising is responsible.

We will continue to work across Government to consider what other measures might be needed to reduce the negative impact that excessive alcohol consumption has on health, crime and the economy. The Government are committed to shortening the amount of time spent in ill health, and to preventing premature deaths. The commitment to labelling in the 10-year plan is a crucial first step to support people to make healthier choices about alcohol. It is the beginning, not the end. We will continue to work across Government to consider what other measures might be needed to reduce the negative impact of excessive alcohol consumption.

My hon. Friend the Member for Lancaster and Wyre also talked about public health as a licensing objective. Evidence to support its impact is, at the moment, somewhat limited, but we continue to work with the Home Office to consider how best to use licensing powers to support local leaders to address alcohol-related harms. I thank my hon. Friend the Member for Easington for his leadership on this important issue. Officials are considering that report from the APPG on drugs, alcohol and justice. I recently met the Minister for Policing and Crime Prevention, my right hon. Friend the Member for Kingston upon Hull North and Cottingham (Dame Diana Johnson), who leads on alcohol and drugs policy across Government. I will soon meet Lord Timpson to discuss those areas and their impact on prisons. We are working across Government. I would be happy to meet the APPG, as I have previously agreed. Diary pressures are very high at the moment, but I am confident that we will soon find time to do that.

We have also talked about preventing under-age drinking, which was raised by my hon. Friend the Member for Coatbridge and Bellshill. There is a commitment in the 10-year plan to make the sale of alcohol-free drinks also illegal to under-18s, ensuring that no-alcohol and low-alcohol products do not become a gateway to standard-strength alcoholic drinks. On alcohol misuse and mental health support, raised by the hon. Member for Winchester (Dr Chambers), we totally agree on the importance of mental health support. The Government are committed to recruiting 8,500 new mental health workers, and have already recruited 6,700.

The shadow Minister, the hon. Member for Sleaford and North Hykeham (Dr Johnson), cheerily reminded us that all activities are risky. She talked of improving the understanding of alcohol dependency. She focused broadly on alcohol use, but did not necessarily mention cancer. To avoid digressing from the debate, I commit to writing to her further on the areas she raised more generally on alcohol policy.

I thank everyone for their contributions to this important debate. We will continue to work across Government to reduce the negative impact that excessive alcohol consumption has on health—including cancer—crime and the economy.

Services for Adults with Learning Difficulties: Hillingdon

Ashley Dalton Excerpts

Friday 4th July 2025 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

I thank my hon. Friend the Member for Uxbridge and South Ruislip (Danny Beales) for securing this debate around services in the community for people with a learning difficulty in Hillingdon, and for championing the rights of people with learning difficulties in his area. I welcome those in the Gallery who are here to demonstrate how important services for people with learning difficulties in Hillingdon are to them. I join my hon. Friend in paying particular tribute to Oliver, Doug, George and Georgia for all their work in this area.

I am aware that, as a member of the Health and Social Care Committee, my hon. Friend has a keen interest in health and social care matters. He will therefore be pleased to know that the Government have today published their response to the Health and Social Care Committee report “Adult Social Care Reform: the cost of inaction”. I am sorry to hear that Hillingdon council has decided to close the Rural Activities Garden Centre, but as Members know, decisions on local services are for councils to make since they are best placed to understand and meet the needs of their local populations.

[John McDonnell]

I fully appreciate the point that the Minister makes, but will she take advice from colleagues in other Departments on the following specific point? My hon. Friend the Member for Uxbridge and South Ruislip (Danny Beales) and I have been working with different groups and we have sought to register, under relevant legislation, the Rural Activities Garden Centre as a community asset, which would force the local authority to properly consult with us and to engage with the wider community. The council is going ahead with the decision to sell or close in advance of even considering whether it should be a community asset. Will she help us by taking advice, from whichever Department is relevant, about whether or not there is anything we can do, as a Government, to ensure that Hillingdon council abides by the legislation that was passed to protect community assets such as this one?

[Ashley Dalton]

I will ensure that that issue is raised with the relevant Department. I will say a little more about some of the expectations we place on local authorities to shape their care markets to meet the diverse needs of all local people, as required under the Care Act 2014.

This Government recognise the vital importance of co-production and working with people who draw on care and support. To ensure local authorities are meeting these duties, the Care Quality Commission are assessing local adult social care services by publishing a full report and overall performance rating for each local authority. Hillingdon has been rated as “Good” in the CQC’s recent assessment, but the report also includes feedback on areas where the CQC concluded that Hillingdon could improve.

It is great to be having this discussion today, on the last day of Co-production Week, an important annual awareness campaign to recognise the benefits of working in equal partnership with people using health and social care provision. Local councils should absolutely involve, engage and consult adults with learning difficulties on their care plans, as well as on wider decisions that affect their care and support, and their lives in general. We are committed to encouraging genuine co-production between social care professionals, local authorities, policymakers and, crucially, people who draw on care and support, to design a system that works better for everyone—one that is fair, inclusive and puts people first.

The Government recognise that investment in local services in the community is vital. That is why we have made available over £69 billion for local government this financial year, increasing core spending power by up to 6.8% in cash terms on last year. For Hillingdon, that means a total of £266.3 million in its core spending power for this year, an increase of 6.2% on 2024-25.

We strongly encourage councils to apply elements of good market-shaping practice involving providers. My hon. Friend the Member for Uxbridge and South Ruislip talked about how people with learning disabilities should be worked with across the Government, but actually that applies to all Government, because we seek to serve the people and that includes people with learning disabilities.

Yesterday, we published our 10-year plan. I am delighted that social care will, for some people, be a key part of the neighbourhood health services we discussed, but the adult social care system is in need of wider reform. We have already begun that journey, including legislating for a fair pay agreement and the independent commission into social care. Over time, the neighbourhood health service and the national care service will work hand-in-hand with each other to help people stay well and live independently.

To conclude, I note my hon. Friend’s invitation to visit Hillingdon and I will ensure that that invitation is extended to the relevant Minister. I once again thank him for bringing forward this important debate, and every Member who has contributed. I hope that Hillingdon council takes notice of this debate.

Question put and agreed to.

NHS 10-Year Plan

Ashley Dalton Excerpts

Thursday 3rd July 2025 Commons Chamber

[Wes Streeting]

My hon. Friend is absolutely right; it was on a snowy day of campaigning for him in Bury North that I received the phone call that would change my life, giving me my kidney cancer diagnosis. Despite that fact, I have since been back to Bury North; I am not saying that it was his bad luck—

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

It was not causation.

[Wes Streeting]

It was coincidence rather than causation, as my hon. Friend the cancer Minister says—although, given both our experiences, we will rethink our visit schedule to Bury.

On a serious note, my hon. Friend the Member for Bury North (Mr Frith) is absolutely right to make the link between poverty, particularly child poverty, and ill health. The last Labour Government lifted 400,000 children out of poverty; I am so proud to think that when in the first year of this Labour Government we chose to extend free school meals to half a million children from low-income families, with that one measure on one day we lifted 100,000 children out of poverty. That is the difference Labour Governments make, and that is how we will deliver not just an NHS fit for the future, but a fairer, more equal, more just society.

Rare Cancers Bill

Ashley Dalton Excerpts

Committee stage
Wednesday 2nd July 2025 Public Bill Committees

[Dr Caroline Johnson (Sleaford and North Hykeham) (Con)]

It is a pleasure to serve under your chairmanship, Mr Stuart. I congratulate the hon. Member for Edinburgh South West on bringing forward this very important piece of legislation. I declare an interest as a consultant paediatrician who has looked after a number of children with rare conditions such as teratoma, rhabdomyosarcoma, Wilms’ tumour and retinoblastoma, to name but a few.

One of the issues with rare cancers, which transposes to rare diseases in general, is that they are often diagnosed late, because people do not recognise that they have symptoms of a rare disease and their health professionals are not as familiar with them because they are rare. The presentation and diagnosis are then late and, as such, the treatment is more difficult. That is compounded further because there has been less research on those topics, so it is not clear what the best treatment for those conditions is. On top of that, the patient may have to travel very long distances to see a specialist who is familiar with the condition, adding both logistical difficulty and cost to that patient’s care.

Some steps are in place to try to improve the situation. The orphan drug regime gives market exclusivity for 10 years, and it provides for lower and refunded fees from the Medicines and Healthcare products Regulatory Agency for the services it provides. Nevertheless, it can still be non-commercially advantageous to put money into developing a drug that is going to be used on no more than a handful of people, however beneficial it is for the individuals concerned.

I welcome the Bill, but wish to make a couple of points. First, in principle it is best that trials are first broached with the patient by a member of their healthcare team. Of course, a member of any given healthcare team—I speak as one myself—will never be aware of all the trials available to all patients at any one time. I welcome the Lord O’Shaughnessy review—commissioned by the last Government and accepted by the current one—which talks about getting a consensus on how best patients can be informed of trials. I wonder whether we should have a system in which patients opt out of not the trial itself but being asked about trials. At the outset, they could be asked, “Would you like to receive information on trials—yes or no?”, so that more people can be aware of how they can contribute. When people are diagnosed with something rare, they often want to contribute to helping others who will come after them.

Will the Minister tell us more about the national cancer plan, which was consulted on earlier this year? I welcome the fact that the children and young people cancer taskforce, which was paused, is being reinstituted. Also, how will the Bill apply to repurposed drugs? Sometimes new medicines are developed for a particular condition, but we often find that medicines can be reformulated and used in a different way to provide a different form of treatment to help individuals with a different condition. How will that apply in respect of both the measures in the Bill and the O’Shaughnessy review?

As a paediatrician, I am very pleased that the Bill applies to children. Overall, I think the Bill is great. It offers hope for many in the future. Will the Minister say something about other rare conditions? As well as rare cancers, people get other rare conditions, and they are affected by the same challenges with research and treatment, and by delays in diagnosis and travel.

Overall, doctors are able to save people’s lives, and improve people’s lives, one at a time, but Parliament and research offer the opportunity to do that on a much bigger scale. I am very grateful to the hon. Member for Edinburgh South West for what he is doing today.

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

It is a pleasure to serve under your chairmanship, Mr Stuart. I congratulate my hon. Friend the Member for Edinburgh South West on his Bill reaching Committee stage. That is a huge achievement for any colleague, but especially for one who has served in this place for almost exactly a year to the day. The Government welcome contributions from Back Benchers, we welcome effective scrutiny from Committees, and we value the vital role that Parliament plays in holding us to account.

In April, my right hon. Friend the Prime Minister announced that clinical trials would be fast-tracked to accelerate the development of the medicines and therapies of the future. Through this new drive, patients will have improved access to new treatments and technologies. We see the Bill as contributing to that ambition. We want to go further for patients with rare cancers, and this legislation will act to incentivise recruitment, oversight and accessibility of rare cancer research, so that NHS patients are at the front of the queue for cutting-edge treatments.

Clause 1 will ensure our regulatory competitiveness. It places a duty on the Government to publish a review of the legislation around orphan drugs within three years of the Bill becoming an Act. The review will examine our legal framework and compare our approach to that of our international partners. We want the UK to lead the world in this space, as the prime destination for clinical research.

Clause 2 will raise the profile of research for rare cancers by placing a new duty on the Secretary of State for Health and Social Care to facilitate and otherwise promote research in this area. The Government want to give patients greater choice and control over their healthcare, and rare cancer patients should have access to research if they choose.

The clause also ensures that the Government will develop a bespoke registry service for rare cancers, to be delivered through the “Be Part of Research” programme—our groundbreaking research registry service provided by the National Institute for Health and Care Research—and that we will appoint a national specialty lead for rare cancers, which we will designate within the NIHR research delivery network, who will have oversight of the overall rare cancer studies portfolio in England.

The Government are committed to going further for rare cancer patients, and that means making clinical trials more accessible. Clause 3 will introduce an innovative solution to allow rare cancer patients to be contacted as quickly as possible about clinical research. The clause creates a new power to allow patient data to be shared from NHS England information systems.

[Dame Siobhain McDonagh (Mitcham and Morden) (Lab)]

Does the Minister agree that keeping a list of people with rare cancers is only any use as long as there are some drug trials? Last night we launched a first trial, in my sister’s memory, for glioblastoma, with every penny raised by people donating, holding bake sales and running marathons. Is that any way to tackle rare cancer?

[Ashley Dalton]

I congratulate my hon. Friend on the launch of the trial in her sister’s name. We do want to see more research and trials coming forward, particularly for rare cancers. She will be aware of the consortium that the Department has developed to work directly with the brain tumour community in particular, to improve the quality and number of research trials that come forward for funding.

[Josh Fenton-Glynn (Calder Valley) (Lab)]

Constituencies in Yorkshire, such as the one I represent, do particularly poorly with research funding—I think 5% of research funding for cancer trials goes to the area. With this Bill and a renewed focus on cancer, I hope we will look to expand the number of research-active hospitals to give people throughout the country a better chance.

[Ashley Dalton]

I should clarify that there is no regional specificity in the allocation of research funding. We welcome all funding bids for research on cancer and rare cancers from anywhere in the country, and I encourage them to come forward.

The new power in clause 3 to allow patient data from NHS England information systems to be shared will allow more patients to be contacted about existing trials. Practically, it will allow us to join up data from the national disease registration service with “Be Part of Research”. As I have said, we are encouraging people to bring forward more research proposals, all of which are considered.

For the first time, patients with a rare cancer could be automatically contacted about research opportunities that are relevant to them and offered innovative new treatments, which means rare cancer patients could have access to research at their fingertips. That is the kind of change that the Government support as part of the shift we are making from analogue to digital—one of the three shifts that will be covered in the 10-year plan that will be launched tomorrow, when more details will become clear.

Clause 4 covers the Bill’s territorial extent. Due to practical and legal differences between the nations, the devolved Governments did not wish to legislate in their individual countries. Our manifesto promised to reset our relationship with the devolved Governments, and we have developed the Bill with them. I am delighted that they expressed their support on Second Reading. Clauses 5 and 6 cover the Bill’s commencement and title. The Government are fully committed to supporting the Bill through the next stages so it can become the Rare Cancers Act 2025.

The shadow Minister talked about the national cancer plan, which I can confirm is being worked on. We have had over 11,000 representations on that plan, which will be published later this year, following the publication of the national 10-year plan for health tomorrow. The children and young people cancer taskforce was launched earlier this year and continues to meet, and has now ensured that young people and children’s voices are part of the taskforce.

[Clive Jones (Wokingham) (LD)]

When the national cancer strategy is published, I hope that part of it will focus on boosting the survival rates for rare cancers. Will the Minister confirm that that will be an important part of the strategy?

[Ashley Dalton]

I can confirm that the overall objective of the whole cancer plan will be saving lives and reducing the number of lives lost to cancer, including rare cancers. The plan will be published later this year.

It is important to note that the Bill is specific to cancer; there will be opportunities to discuss other rare conditions in the future. I thank my hon. Friend the Member for Edinburgh South West for presenting the Bill, and I pay tribute to the charities that are backing him, some of which I had the pleasure to meet recently to discuss further how the Government can better support people with rare cancers. Together, we will improve outcomes for people across our country, and I look forward to working with everybody to get that done.

[Dr Arthur]

I am grateful for all the contributions to debate. The charity partners carefully picked the Committee members, given their interest in this subject, and we can see the benefit of that.

I thank the hon. Member for South Antrim for his efforts to make sure that the legislation works in Northern Ireland. I am also grateful for the comments from the hon. Member for Wokingham and my hon. Friend the Member for Calder Valley, who both asked for more progress in this area generally.

Of course, I have to mention my hon. Friend the Member for Mitcham and Morden. I attended the reception yesterday evening and, first and foremost, it was a fantastic celebration of her sister’s fantastic life. We should be grateful for her. I wish Paul Mulholland and his team all the best with that trial. It really did fill me with hope to hear that update from him.

My hon. Friend the Member for Mitcham and Morden mentioned marathons, so at this point I have to mention my daughter, Ruth Arthur, who ran the marathon in Edinburgh for the Brain Tumour Charity and raised just over £3,000 in the memory of her grandfather. I am very proud of her.

I am grateful for the shadow Minister’s comments and the insight and depth of thinking she brought to the debate. One of the best things about this journey has been working with the DHSC team who are working on the cancer strategy, and seeing how much they care about getting this right. We have often reflected on the point that the shadow Minister made about diagnosis. Too often when we go to events in this place hosted by charities that include somebody with life experience, late diagnosis is where their story starts. It is often avoidable. It is fantastic that the DHSC cancer team acknowledge that. Hopefully our GPs in particular will get more support to make sure that the early signs are not missed and the dots are joined together. It is good to see the Minister nodding vigorously as I say that. I thank her for her leadership right across this policy area and for her support for the Bill in particular.

I thank all Committee members for coming along today and contributing, and I thank the civil servants who helped to draft the Bill. If it passes—and I really hope it does—it will incentivise and create an environment in which more research into rare cancers is fostered, potentially helping us to save, in the longer term, perhaps thousands of lives. What an aspiration that is. I once again commend the Bill to the Committee.

Clause 1 accordingly ordered to stand part of the Bill.

Clauses 2 to 6 ordered to stand part of the Bill.

Bill to be reported, without amendment.

Infant Feeding

Ashley Dalton Excerpts

Tuesday 1st July 2025 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

I congratulate the hon. Member on securing the debate. Through her leadership of the all-party parliamentary group for infant feeding, she is working to ensure that families across the country get the right support. I thank all hon. Members who have contributed—my hon. Friends the Members for Ribble Valley (Maya Ellis), for Altrincham and Sale West (Mr Rand), for South Derbyshire (Samantha Niblett) and for Brecon, Radnor and Cwm Tawe (David Chadwick), the hon. Members for Strangford (Jim Shannon) and for Exmouth and Exeter East (David Reed), and yourself, Madam Deputy Speaker.

The number of interventions and contributions has shown how important the issue is and how deeply it is felt across the House. The hon. Member for Chichester asked about the 10-year plan. I will not go into detail about what is in it, but—tick, tock—she does not have to wait long as the plan will be launched on Thursday morning.

I look forward to working with colleagues across the House and the wider health landscape on how we deliver the plan. In that plan, they will see that children’s early years are crucial to their development, health and life chances. That is why the Government are taking a mission-based approach to raising the healthiest generation of children ever and to ensuring that every child has a healthy, happy start to life.

[Dr Danny Chambers (Winchester) (LD)]

To reiterate the comments made by my hon. Friend the Member for Chichester (Jess Brown-Fuller) and the Minister about all children needing to have a healthy start, we cannot emphasise enough how important gestation and the first six months of life are. The factors that affect gestation and the first six months of life have a bigger impact on long-term health than anything we can do after that—any conscious decisions we make about our health are less impactful than what has happened to us during gestation and the first six months of life.

[Ashley Dalton]

I agree. The hon. Member will see in the 10-year plan and some of the investments we are making—for instance, to reduce the number of women smoking in pregnancy—that the Government recognise that.

We recognise that infant feeding is critical to a baby’s healthy growth and development, and we recognise the significant benefits of breastfeeding for both mothers and babies. We are fully committed to supporting families to breastfeed should they choose to do so. We know that most mothers want to breastfeed, but many stop before they would ideally like to. While it has been positive to see many more mothers continuing to breastfeed in recent years, we know that they can face complex barriers to achieving their infant feeding goals.

I recognise the concerns raised through the World Breastfeeding Trends Initiative report on the UK infant feeding policy landscape. Health is devolved, and I would like to commend Northern Ireland for its performance in this area, which was raised by the hon. Member for Strangford. However, we know through the report that England scores poorly, and we want to change that.

Families need quality services, trustworthy information, affordable options and systems that support them, not hinder them. Midwives and maternity services play a crucial role through the perinatal period in preparing and supporting families around infant feeding. We have committed to training thousands more midwives to better support women throughout their pregnancy and beyond, and there has been an increase of over 1,300 full-time equivalent midwives in the workforce since April 2024. We will publish a refreshed workforce plan to deliver the transformed health service that we will build over the next decade.

To drive forward improvement in maternity and neonatal services, we announced the launch of a national independent investigation into maternity and neonatal care. The investigation will recommend one set of national actions by December. A national maternity and neonatal taskforce, chaired by the Secretary of State, will then bring together independent experts to co-produce a national plan to drive improvement.

As families transition from maternity services to the community, it is important that they continue to receive the support they need, and health visitors are key to this. However, we know that health visitor numbers have decreased and there is variation in the level of services across the country, but it remains a universal service, and we are committed to that. In the plan for change, we committed to strengthening health visiting services so that all families can access their support.

We are investing in family hubs and the Start for Life programme, with £18.5 million this year to improve infant feeding support across 75 local authorities in England. Start for Life services are helping parents to access support where they need it and in a location that suits them, whether that is their home, their family hub, a hospital setting or through the many voluntary sector organisations that have been referred to today. Local authorities are working with partners to embed local infant feeding strategies, joining up services for seamless support and tailoring them to their community, with both universal and targeted support. They are building up the workforce, investing in infant feeding specialists, delivering high-quality training and expanding networks of peer supporters. Funding is also helping to train staff to identify complex needs early such as tongue-tie, and to offer timely support.

Although long-term evaluation is needed to understand the full impact of the programme, some promising findings are emerging. For example, ambitious multi-layered integrated infant feeding plans have led to increased breastfeeding rates in Coventry, and local health visitor data shows an increase in breastfeeding at six to eight weeks from 51% to 57% in just 18 months. We are also helping families across the UK to access breastfeeding support 24 hours a day through the National Breastfeeding Helpline.

[Jess Brown-Fuller]

The Minister highlights some brilliant examples that are a gold standard in care, but does she recognise that the process the Government are currently undertaking, with only half of local authorities being funded, means that we still end up with a patchwork level of support for new mothers? They do not know where they are meant to go, because it is different when they cross a county border.

[Ashley Dalton]

This is very much targeted through the family hub service and support for Start for Life, and through the universal health visiting offer and the National Breastfeeding Helpline we aim to offer all women who are breastfeeding the support that they need to do so. Parental leave has been touched on, and we know that supporting parents goes beyond services. Returning to work can influence how families choose to feed their babies, and in the plan to make work pay we have committed to a review of the parental leave system. As the hon. Member said, that review was launched by the Department for Business and Trade in the Chamber earlier today, and we are delighted to see that come forward.

I have spoken a lot about breastfeeding, but we absolutely recognise that when families cannot or choose not to breastfeed, it is vital that they get formula that is safe, nutritionally complete and affordable. Infant formula regulations and Competition and Markets Authority recommendations are important, but we know that many families are struggling to afford infant formula. We welcome the report from the CMA into the UK infant and follow-on formula market. It highlighted some of the issues that the hon. Member raised, in particular by noting that families rely on brand reputation and price as a proxy for quality, often choosing more expensive products. However, specific regulations require all infant formula to comply with robust nutritional and compositional standards, so that all infant formula sold on the UK market meets the nutritional needs of babies, regardless of the price or brand.

The CMA has made 11 recommendations to the Government, with four aims: to eliminate brand influence in healthcare settings; to provide better information for parents in retail settings; to strengthen labelling and advertising rules; and to ensure effective enforcement of regulations. The Government are supportive of what the CMA is trying to achieve. We want parents to be confident enough to choose lower-priced products, and for manufacturers and retailers to compete more on price. The CMA recommendations are UK wide. We are considering them alongside colleagues in the devolved Governments, and aim to have a UK-wide response available as soon as possible.

In conclusion, I thank the hon. Member for raising this important matter. The Government are committed to giving children the best start in life, and we do not underestimate the challenge of getting this right for families. We will continue to strengthen key services, build on good practice, and identify where we can have the greatest impact for families. Tomorrow I will meet the all-party group on babies, and I look forward to discussing these issues further with them.

Question put and agreed to.

Rare Cancers Bill (Money)

Ashley Dalton Excerpts

Money resolution
Monday 30th June 2025 Commons Chamber

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

I beg to move,

That, for the purposes of any Act resulting from the Rare Cancers Bill, it is expedient to authorise the payment out of money provided by Parliament of:

(1) any expenditure incurred under or by virtue of the Act by the Secretary of State, and

(2) any increase attributable to the Act in the sums payable under or by virtue of any other Act out of money so provided.

I pay tribute to my hon. Friend the Member for Edinburgh South West (Dr Arthur) for bringing forward this important Bill. The Government support it, and are committed to making a real difference for patients with rare cancers.

[Jim Shannon (Strangford) (DUP)]

Just a quick one—I had hoped to speak to the Minister before she came to the Dispatch Box. In Northern Ireland, rare cancers account for a quarter of all cancer cases in both men and women. Will there be extra money set aside for Northern Ireland, where health is devolved, to deal with rare cancers? It is not just those who have rare cancers who have to deal with them; their families do, too. I ask that question of the Minister genuinely and respectfully.

[Ashley Dalton]

As the hon. Gentleman said, health is devolved. I am happy to write to him with the details of how we expect this private Member’s Bill to be implemented by the devolved Governments.

Question put and agreed to.

Preventing Ill Health

Ashley Dalton Excerpts

Monday 30th June 2025 Written Statements

[The Parliamentary Under-Secretary of State for Health and Social Care (Ashley Dalton)]

Today I am updating the House on some of the steps the Government will take to prevent and delay the onset of ill health, thereby restoring the means for people to lead a healthy life in places where it has become most difficult, and in turn reducing pressure on the NHS.

Healthy food standards

Obesity is one of the leading causes of ill health, costing the NHS £11.4 billion per year. Obesity rates have doubled in the last 30 years, and one in five children now leave primary school with obesity. In the 2023-24 school year, the prevalence of obesity was more than twice as high among children living in the most deprived areas as among children living in the least deprived areas. We will only tackle this successfully by taking a whole-of-society approach in which Government partners with industry to drive innovation and give people the power to make healthy choices.

We are announcing plans to work with the food industry to combat rising childhood obesity. Under new proposals, all large food businesses will be mandated to report against standardised metrics on healthier food sales by the end of this Parliament. This will set full transparency and accountability around the food that businesses are selling and encourage healthier products. Publishing this data annually will also support business investors to invest in healthier companies, by seeing which are performing well, encouraging further reformulation and development of new healthy foods.

Using that reporting, we will set new mandatory targets to increase the healthiness of sales in all communities, and will work with the Food Strategy Advisory Board on how to sequence the introduction of this policy. We want to use smarter regulation that makes the most of industry’s innovation and experience. Businesses will have the freedom to decide how they achieve the target—through improving products, introducing new healthier products, or changing loyalty schemes to make healthier products more available, and available to all. Public health experts believe small improvements to the average meal to reduce daily calorie intake by just 40-50 kcals could lead to 340,000 fewer children and two million fewer adults living with obesity.

We will engage with industry closely as we develop and consult on these proposals. We intend to work with all the devolved nations to ensure regulatory alignment for food businesses, and to achieve the maximum reduction of obesity we can across the UK.

NHS weight management services

We will be asking the NHS to do more to support our approach to prevention. To support people already living with obesity, we will double the number of patients referred to the NHS digital weight management programme, offering help proven to deliver results to 125,000 more people every year. Additionally, pioneering relationships with the biggest pharmaceutical companies will be brokered to expand access to weight loss services and treatments across the NHS, ensuring fairer access to weight loss drugs for those who cannot afford private prescriptions.

Vaccines

Vaccinations are, after access to clean water, the most effective public health intervention in the world for saving lives and promoting good health. However, uptake, particularly for children, has been in gradual decline for over a decade. Improving uptake will protect our children from infectious disease, reduce the burden on the NHS, and help consign some diseases to history, such as cervical cancer. To improve access to vaccinations, we are enhancing access to general practices for vaccinations, testing models to deliver vaccinations to some families through health visits, and expanding the role of community pharmacy, including offering catch-up vaccinations to protect against human papillomavirus.

We are expanding the NHS app, so that everyone knows what vaccinations they have had, what they need, and where to get them, at a time and location that meets their needs. Patients will be able to book jabs on the NHS app. Parents will be able to access a new vaccination hub on the NHS app, on behalf of their child, during 2026-27. Finally, we will launch the world’s first gonorrhoea immunisation programme to protect at-risk adults and help prevent the rise of antimicrobial resistance.

Health store app marketplace

We will build a health store app marketplace. We want to empower people to manage their own health and care, putting the ability to treat, manage and prevent conditions into the hands of our population. Successful adoption of digital health technologies across a range of clinical areas including mental health, cardiovascular health and musculoskeletal conditions may lead to improved patient outcomes, reduced waiting times and improved economic activity, by supporting people to stay in or return to work.

The health store will ensure that the products with the best evidence reach the hands of patients, irrespective of where you live across the country. The National Institute for Health and Care Excellence will play a crucial role in evaluating technologies, guaranteeing clinical effectiveness for patients and cost-effectiveness for the NHS. We will explore central funding for those technologies with an effective evidence base, as determined by NICE, making the NHS an attractive market that centrally supports innovation.

NHS points scheme

We are announcing a new NHS points scheme, which will be developed to reward people for taking positive actions to improve their health. Based on loyalty schemes popular with supermarkets, coffee shops and mobile banking apps, people could receive gift vouchers or discounts at their favourite high-street stores by simply upping their step count or making healthier food choices. We will shortly launch a market engagement process to start the conversation with business about what behaviours could be incentivised.

Musculoskeletal conditions

To further improve how patients in England engage with the NHS, and where it is clinically appropriate for them to do so, patients will be able bypass GPs to directly access specialist treatment using the NHS app, including treatment for MSK, mental health talking therapies, podiatry and audiology services. This will help deliver faster treatment for patients, while enabling GPs to focus on more complex cases by reducing pressure on them.

Tobacco

In addition to the measures set out, the Government are determined to put an end to the harms of tobacco. Smoking is still the biggest killer—it claims around 80,000 lives a year, causes one in four of all cancer deaths in England and kills up to two thirds of its long-term users. Our landmark Tobacco and Vapes Bill will help deliver our ambition for a smoke-free UK. It will create a smoke-free generation, gradually ending the sale of tobacco products across the country and breaking the cycle of addiction and disadvantage. The Bill will also strengthen the existing ban on smoking in public places. And while we know vapes are less harmful than smoking and can be an effective quit aid for smokers, we are doing more to protect children from the risks of harm and addiction. The Bill will stop vapes from being deliberately branded, promoted, and advertised to children to stop the next generation from becoming hooked on nicotine.

The full set of prevention measures, which will further set out how we deliver healthier, more prosperous lives for all, and help reduce health inequalities, build a stronger labour market and lower NHS demand, will be set out shortly in the Government’s 10-year health plan for England.

[HCWS756]